Scientists are working to discover new and effective ways precision medicine can prevent, diagnose, and treat diseases such as cancer.
Learn about the common challenges and risks associated with accelerating your molecule's timeline from lab to clinic, along with important supply chain considerations for emerging biopharma companies.
Partnering with a CDMO that offers comprehensive and robust E&L studies can help facilitate a smooth product launch by ensuring minimal impact from impurities, all while mitigating risks.
By utilizing cells from donors which are then modified and stored in large batches, allogeneic therapies enable accelerated timelines and larger-scale preparation.
Discover key considerations when selecting resin options for mAb purification, including alternatives to the conventional affinity capture step.
The biopharmaceutical industry is increasingly employing micro-flow imaging for particle characterization, owing to the superior insights it can afford into product quality and process controls.
Here, we examine the cause and impact of common errors in Quality Control (QC) labs, the strategy for reducing those errors with an intuitive chromatography system, and more.
PCM offers a number of advantages, including streamlined development and increased flexibility. Review the key drivers for PCM as well as the hurdles that stand in the way of industry-wide adoption.
Examine the technologies underpinning the current sensors being utilized in dissolved CO2 measurement devices today and determine which sensors are appropriate for your application.
Discover a modeling approach employing artificial neural networks using experimental factors combined with simulation-derived parameters plus viscosity data from 27 highly concentrated mAbs.
Get the latest articles from Bioprocess Online delivered to your inbox.